Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome and a high bleeding risk: optimization of antiplatelet treatment in high-risk elderly.

Trial Profile

Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome and a high bleeding risk: optimization of antiplatelet treatment in high-risk elderly.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel; Ticagrelor
  • Indications Acute coronary syndromes; Myocardial infarction; Unstable angina pectoris
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms POPular-AGE
  • Most Recent Events

    • 24 Apr 2017 Planned End Date changed from 1 Aug 2017 to 1 Jan 2019.
    • 24 Apr 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jan 2018.
    • 17 Aug 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-001403-37).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top